Evidence map›Paper›PMID 41828646›Full record

ArticleInternational journal of molecular sciences2026

Immune Infiltration, Effector T-Cell Enrichment, and Functional Context for Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.

Ana Demšar, Klara Geršak, Barbara Gazić, Tanja Blagus, Katja Goričar, Gregor Jezernik, Vita Dolžan, Cvetka Grašič Kuhar

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana DemšarFaculty of Medicine, University of Maribor, Taborska Ulica 8, 2000 Maribor, Slovenia.
Klara GeršakGeneral Hospital Izola, Polje 40, 6310 Izola, Slovenia.
Barbara GazićFaculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, Slovenia.
Tanja BlagusFaculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, Slovenia.ORCID 0000-0002-2104-9060
Katja GoričarFaculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, Slovenia.ORCID 0000-0001-5673-4458
Gregor JezernikFaculty of Medicine, University of Maribor, Taborska Ulica 8, 2000 Maribor, Slovenia.ORCID 0000-0003-1110-5345
Vita DolžanFaculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, Slovenia.ORCID 0000-0001-6707-6649
Cvetka Grašič KuharFaculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, Slovenia.ORCID 0000-0001-5047-4034

Funding

Slovenian Research Agency: P3-0321: Prognostic and predictive factors for response in treatment of different types of cancer, P3-0289: Characteristics of malignant neoplasms important for diagnosis, prognosis and treatment outcome and P1-0170: Molecular Slovenian Research Agency: P3-0321: Prognostic and predictive factors for response in treatment of different types of cancer, P3-0289: Characteristics of malignant neoplasms important for diagnosis, prognosis and treatment outcome and P1-0170: Molecular
6 · The paper itself

Abstract

Tumor-infiltrating lymphocytes (TILs) are an established predictor of pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) in breast cancer. However, TILs primarily reflect the extent of immune infiltration and provide limited insight into immune functional state. We investigated whether integrating measures of immune infiltration (TILs), effector T-cell presence (CD8), and functional context (immune checkpoint components) may improve prediction of pCR beyond TILs alone. Pretreatment tumor biopsies from 166 patients with early breast cancer treated with standard NACT were assessed for stromal TILs and mRNA expression of CD8, PD-1, LAG-3, and TIM-3. Associations with pCR were evaluated using univariate and multivariable logistic regression, and composite immune phenotypes were constructed to capture functional immune states. In univariate analyses, higher TILs, CD8, PD-1, and LAG-3 were associated with pCR (all

Indexed as

Breast NeoplasmsCD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingNeoadjuvant TherapyAdultAntigens, CDBiomarkers, TumorFemaleHepatitis A Virus Cellular Receptor 2HumansLymphocyte Activation Gene 3 ProteinMiddle AgedPathologic Complete ResponseProgrammed Cell Death 1 ReceptorTumor MicroenvironmentAntigens, CDBiomarkers, TumorHepatitis A Virus Cellular Receptor 2Lag3 protein, humanLymphocyte Activation Gene 3 ProteinPDCD1 protein, humanProgrammed Cell Death 1 Receptorbreast cancerCD8-positive T cellsimmune microenvironmentneoadjuvant chemotherapypathological complete responsePD-1 immune checkpointpredictive biomarkerstumor-infiltrating lymphocytes

Identifiers

PMID41828646
PMCPMC12985902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.